FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3091181510> ?p ?o ?g. }

• W3091181510 endingPage "104324" @default.
• W3091181510 startingPage "104324" @default.
• W3091181510 abstract "In this article, we describe the synthesis of 3-phenylquinoxaline-2-carbonitrile 1,4-dioxides bearing cyclic diamine residues at positions 6 or 7; the synthesis is based on the nucleophilic substitution of halogens. All synthesized 6(7)-aminoquinoxaline-2-carbonitrile 1,4-dioxides 3–6 demonstrated higher cytotoxicity and hypoxia selectivity compared to the reference agent tirapazamine against breast adenocarcinoma cell lines (MCF7, MDA-MB-231). The structure and position of the diamine residue considerably affects the antiproliferative properties of the quinoxaline-2-carbonitrile 1,4-dioxides. The introduction of a halogen atom at position 7 in the quinoxaline ring of 4a considerably increases the cytotoxicity of compounds 5a and 6a under both normoxic and hypoxic conditions. However, the most hypoxia-selective derivatives were non-halogenated 7-aminosubstituted 3-phenylquinoxaline-2-carbonitrile 1,4-dioxides 3a–j. Of the 32 novel synthesized derivatives, approximately 20 of the 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides demonstrated high antiproliferative potency against wild type leukemia cells K562 and drug-resistant subline K562/4 with the expression of p-glycoprotein (p-gp) compared to the reference agent doxorubicin, which exhibited one order of magnitude lower activity towards K562/4 cells than towards K562 cells. Lead compounds 5a and 3f inhibited HIF-1α expression and activity and induced apoptosis in hypoxic tumor cells, which was confirmed by poly(ADP-ribose)polymerase (PARP) cleavage. Moreover, 5a and 3f showed strong antiestrogenic potencies in MCF7 breast cancer cells. Thus, the described series of quinoxaline 1,4-dioxides has high anticancer potential and good aqueous solubility. Therefore, these compounds are promising for further drug development of hypoxia-targeted anticancer agents." @default.
• W3091181510 created "2020-10-08" @default.
• W3091181510 creator A5009576349 @default.
• W3091181510 creator A5019712475 @default.
• W3091181510 creator A5023902397 @default.
• W3091181510 creator A5026537811 @default.
• W3091181510 creator A5047681158 @default.
• W3091181510 creator A5069914829 @default.
• W3091181510 creator A5072049335 @default.
• W3091181510 creator A5074705164 @default.
• W3091181510 creator A5085007680 @default.
• W3091181510 date "2020-11-01" @default.
• W3091181510 modified "2023-10-15" @default.
• W3091181510 title "Discovery of derivatives of 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: novel, hypoxia-selective HIF-1α inhibitors with strong antiestrogenic potency" @default.
• W3091181510 cites W147439079 @default.
• W3091181510 cites W1521411817 @default.
• W3091181510 cites W1534996404 @default.
• W3091181510 cites W1547961512 @default.
• W3091181510 cites W1549271450 @default.
• W3091181510 cites W1970292996 @default.
• W3091181510 cites W1970744454 @default.
• W3091181510 cites W1974302097 @default.
• W3091181510 cites W1978486090 @default.
• W3091181510 cites W1986848430 @default.
• W3091181510 cites W1987050459 @default.
• W3091181510 cites W2007287727 @default.
• W3091181510 cites W2024903578 @default.
• W3091181510 cites W2026123721 @default.
• W3091181510 cites W2029017772 @default.
• W3091181510 cites W2030680262 @default.
• W3091181510 cites W2045031843 @default.
• W3091181510 cites W2057366549 @default.
• W3091181510 cites W2059205366 @default.
• W3091181510 cites W2061776255 @default.
• W3091181510 cites W2062270235 @default.
• W3091181510 cites W2067491763 @default.
• W3091181510 cites W2072099978 @default.
• W3091181510 cites W2074286288 @default.
• W3091181510 cites W2075236392 @default.
• W3091181510 cites W2080174206 @default.
• W3091181510 cites W2083350334 @default.
• W3091181510 cites W2092458962 @default.
• W3091181510 cites W2094633478 @default.
• W3091181510 cites W2104079713 @default.
• W3091181510 cites W2116508133 @default.
• W3091181510 cites W2125257427 @default.
• W3091181510 cites W2126239759 @default.
• W3091181510 cites W2132454074 @default.
• W3091181510 cites W2146426024 @default.
• W3091181510 cites W2159385549 @default.
• W3091181510 cites W2161891567 @default.
• W3091181510 cites W2170783734 @default.
• W3091181510 cites W2328036388 @default.
• W3091181510 cites W2333473796 @default.
• W3091181510 cites W2344746583 @default.
• W3091181510 cites W2575891648 @default.
• W3091181510 cites W2795990497 @default.
• W3091181510 cites W2888978591 @default.
• W3091181510 cites W2910907845 @default.
• W3091181510 cites W2950681249 @default.
• W3091181510 cites W2950703672 @default.
• W3091181510 cites W2952684114 @default.
• W3091181510 cites W2952715082 @default.
• W3091181510 cites W2952832194 @default.
• W3091181510 cites W2963913257 @default.
• W3091181510 cites W2966079296 @default.
• W3091181510 cites W2990854210 @default.
• W3091181510 cites W4234989914 @default.
• W3091181510 doi "https://doi.org/10.1016/j.bioorg.2020.104324" @default.
• W3091181510 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33142432" @default.
• W3091181510 hasPublicationYear "2020" @default.
• W3091181510 type Work @default.
• W3091181510 sameAs 3091181510 @default.
• W3091181510 citedByCount "7" @default.
• W3091181510 countsByYear W30911815102021 @default.
• W3091181510 countsByYear W30911815102022 @default.
• W3091181510 countsByYear W30911815102023 @default.
• W3091181510 crossrefType "journal-article" @default.
• W3091181510 hasAuthorship W3091181510A5009576349 @default.
• W3091181510 hasAuthorship W3091181510A5019712475 @default.
• W3091181510 hasAuthorship W3091181510A5023902397 @default.
• W3091181510 hasAuthorship W3091181510A5026537811 @default.
• W3091181510 hasAuthorship W3091181510A5047681158 @default.
• W3091181510 hasAuthorship W3091181510A5069914829 @default.
• W3091181510 hasAuthorship W3091181510A5072049335 @default.
• W3091181510 hasAuthorship W3091181510A5074705164 @default.
• W3091181510 hasAuthorship W3091181510A5085007680 @default.
• W3091181510 hasConcept C109316439 @default.
• W3091181510 hasConcept C109541995 @default.
• W3091181510 hasConcept C121608353 @default.
• W3091181510 hasConcept C171122931 @default.
• W3091181510 hasConcept C178790620 @default.
• W3091181510 hasConcept C185592680 @default.
• W3091181510 hasConcept C190283241 @default.
• W3091181510 hasConcept C193042331 @default.
• W3091181510 hasConcept C202751555 @default.
• W3091181510 hasConcept C2780362310 @default.
• W3091181510 hasConcept C2994423619 @default.

• next